Alterity Therapeutics Limited (ATHE)
NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 2.0100 |
| Open | 2.0700 |
| Bid | 1.9900 x 100 |
| Ask | 2.1300 x 100 |
| Day's range | 2.0000 - 2.1100 |
| 52-week range | 1.5500 - 5.4100 |
| Volume | |
| Avg. volume | 84,152 |
| Market cap | 18.071M |
| Beta (5Y monthly) | 0.72 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Alterity (ATHE) Up on Preclinical Parkinson's Treatment Data
Data from a preclinical study shows that treatment with Alterity's (ATHE) lead candidate improved motor performance and general function in monkeys with experimentally-induced Parkinson's disease.
- Simply Wall St.
Alterity Therapeutics Limited's (ASX:ATH) CEO Compensation Is Looking A Bit Stretched At The Moment
Key Insights Alterity Therapeutics' Annual General Meeting to take place on 28th of November CEO David Stamler's total...
© 2024 Yahoo. All rights reserved.